Pharmacy `Clawbacks’ Focus of Newest State Law on PBMs

Bloomberg Gov
A new law in Connecticut would close a drug price loophole that’s been the subject of more than a dozen lawsuits around the U.S., taking aim at a practice by pharmacy benefit managers called pharmacy clawbacks…Read More.

Unaccountable Benefit Managers: How PBMs Put Profits Over Patients

Morning Consult
A young husband was diagnosed with advanced melanoma and tumors attached to his brain. Waiting on the other side of his oncology clinic’s pharmacy counter was a potentially life-prolonging drug…Read More.

Feeling the pain of rising drug prices? Blame the middle man

CBS News
While Washington wrangles with a replacement for Obamacare, patients across the country continue to battle one of the biggest everyday obstacles to good health care: Rising drug prices…Read More.

PBMs: Raising Drug Prices for Seniors… Pocketing “Rebates” for Themselves.

Infographic
Click Here.

Who Decides The Cost of Prescription Drugs?

MSNBC
As prescription drug costs skyrocket, President Trump promises to lower drug prices…Watch Here.

Pharmacy Benefit Managers Contribute to High Drug Costs

CWA
The high cost of prescription drugs is an important issue for our members and employers. A recent investigation into Pharmacy Benefit Managers (PBMs) highlights their role in this trend…Read More.

Drug Rebates Reward Industry Players — And Often Hurt Patients

Kaiser Health News
Medicare and its beneficiaries aren’t the winners in the behind-the-scenes rebate game played by drugmakers, health insurers and pharmacy benefit managers, according to a paper published Tuesday in JAMA Internal Medicine…Read More.

Drug Lobbyists’ Battle Cry Over Prices: Blame the Others

The New York Times
Hundreds of independent pharmacists swarmed the House and Senate office buildings one recent afternoon, climbing the marble staircases as they rushed from one appointment to the next, pitching lawmakers on their plan to rein in the soaring drug prices that have enraged American consumers…Read More.

New Report: PBMs Push Drug Costs

Drug Topics
A new review of studies on the economic impacts of pharmacy benefit managers (PBMs) found that they have an adverse impact on the overall costs and prices of drugs…Read More.

New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs

BioSpace
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States…Read More.

Twitter   LinkedIn